# Rapport Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Sep 18, 2025

- Company: [Rapport Therapeutics, Inc.](/companies/rapp.md) (CIK 2012593)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-18
- Accepted by EDGAR: Sep 18, 2025, 17:32 ET
- Period: not reported
- Accession: 0001104659-25-091350
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2012593/000110465925091350/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2012593/000110465925091350/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2012593/000110465925091350/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-091350. Last ingested by Listed: Nov 4, 2026, 07:39 ET. No prices; not investment advice.
